Biosimilars

Expertise from Working with Innovator Biologic Drugs


A successful biosimilar program requires an in-depth understanding of the structure and function of the originator product to establish a target profile that can be used to evaluate bioanalytical similartity. With over 25 years of biologics drug development experience, Celerion provides an extensive list of bioanalytical assays, immunogenicity assessments and pharmacodynamic biomarkers.

celerion-immunogenicity-screening-1

Immunogenicity Screening


View Case Study f138

Assay Efficiency: Combined Biosimilar & Innovator Assay


Immunogenicity platforms are varied and plentiful, but possess a spectrum of advantages all driven by the particular biologic’s unique characteristics and development needs. The Celerion ScienceTM Team creates immunogenicity strategies across the drug development lifecyle in a customized, adaptive manner.

celerion-biosimilar-assay-sestup

Ready to Get Started?

Contact Celerion to Learn More

Contact Us